NKAPD1
Uncharacterized protein NKAPD1
Also known as: C11orf57, FLJ10726, NKAP1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZUT1
- Gene
- NKAPD1
- Ensembl
- ENSG00000150776
- Chromosome
- 11
- Canonical length
- 292 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Enables identical protein binding activity. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
292 residues, UniProt reviewed canonical sequence.
>Q6ZUT1|NKAPD1
1 MSRIPLGKVL LRNVIRHTDA HNKIQEESDM WKIRELEKQM EDAYRGTKRK MLPSSSSRMR
61 SDGFDEESQR YYWRPKNEIS GTLEDDFLKA KSWNKKFYDY EANMPDRWGH SGYKELYPEE
121 FETDSDQQDI TNGKKTSPQV KSSTHESRKH KKSKKSHKKK QKKRSHKKQK KSKKEATDIT
181 ADSSSEFSEE TGASGTRKGK QPHKRKKKSR KKSLKKPALF LEAESNTSHS DDSASSSSEE
241 SEERDTKKTK RKKREKKAHT SVANNEIQER TNKRTNWKVA TDERSAESSE DDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NKAPD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 31 nTPM
Expression across tissuesHPA
Tissue
- retina: 31 nTPM
- cerebellum: 22 nTPM
- ovary: 19 nTPM
- skeletal muscle: 17 nTPM
- thymus: 16 nTPM
- breast: 16 nTPM
Single-cell type
- esophageal apical cells: 72 nCPM
- rod photoreceptor cells: 51 nCPM
- late primary spermatocytes: 47 nCPM
- megakaryocytes: 37 nCPM
- erythrocyte progenitors: 37 nCPM
- parietal cells: 34 nCPM
Immune cell
- plasmacytoid DC: 21 nTPM
- NK-cell: 14 nTPM
- naive CD4 T-cell: 11 nTPM
- memory CD4 T-cell: 10 nTPM
- MAIT T-cell: 10 nTPM
- gdT-cell: 9.9 nTPM
Brain region
- cerebellum: 22 nTPM
- white matter: 18 nTPM
- cerebral cortex: 17 nTPM
- pons: 17 nTPM
- hypothalamus: 17 nTPM
- basal ganglia: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.61
- gnomAD pLI
- 0.31
- DepMap mean gene effect
- -0.29
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Protein domainsUniProt · Pfam · InterPro
- NF-kappa-B-activating protein
- Nkap domain containing 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NKAPD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NKAPD1 as an antibody target. Whether an autoantibody or antibody against NKAPD1 could matter depends on whether native NKAPD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NKAPD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NKAPD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...